Seeing Is Believing
with an average price target of $243709.87. This is a potential upside of $243703.5 (3825800.63%) from yesterday's end of day stock price of $6.37.
Cyclacel Pharmaceuticals's activity chart (see below) currently has 6 price targets and 7 ratings on display.
Analysts average stock forecasts to be materialized ratio is 75% with an average time for these price targets to be met of 176.25 days.
Most recent stock forecast was given by JONATHAN ASCHOFF from ROTH MKM on 03-May-2024. First documented stock forecast 27-Apr-2020.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 27-Apr-2020
$176
$169.63 (2662.95%)
$336
1 years 10 months 30 days ago
(03-May-2024)
3/3 (100%)
$-51.63 (-22.68%)
60
Buy
$8
$5.1 (175.86%)
$10
2 years 10 months 8 days ago
(25-May-2023)
3/3 (100%)
$-2.05 (-20.40%)
30
Buy Since 19-May-2020
$5280
3 years 26 days ago
(07-Mar-2023)
1/1 (100%)
$-2180.71 (-29.23%)
615
Buy Since 13-May-2020
$979199.5
$979193.12 (15371949.00%)
3 years 8 months 15 days ago
(18-Jul-2022)
0/3 (0%)
$977048.38 (45420.03%)
What is CYCC (Cyclacel Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on CYCC (Cyclacel Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on CYCC (Cyclacel Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on CYCC (Cyclacel Pharmaceuticals)?
Which analyst is the currently most bullish on CYCC (Cyclacel Pharmaceuticals)?
Which analyst is the currently most reserved on CYCC (Cyclacel Pharmaceuticals)?